Trump says Pfizer will sell some drugs at 'most‑favored nation' prices, claiming 50–100% cuts
President Trump announced a deal with Pfizer under which some medications would be sold at a "most‑favored nation" cost, and he claimed those prices could fall by 50–100%. The White House is also building a "TrumpRX" website to publicize the initiative.
Corporate News
Economy
Health
Politics
🔍 Key Facts
- President Trump said some medications will be sold at a 'most‑favored nation cost' under a deal with Pfizer.
- He used the phrase "most‑favored nation cost" to describe the pricing arrangement with Pfizer.
- The president claimed that some drug prices could fall by 50%–100%.
- His comments referred to "some medications" rather than stating all drugs would be affected.
- The report was published by CBS News on its Facebook page on 2025-09-30 under the headline: "Trump says some medications will be sold at reduced \"most-favored nation cost\" in Pfizer deal."
📍 Contextual Background
- On 2025-09-22, President Donald Trump publicly stated that acetaminophen (Tylenol) "can be associated with a very increased risk of autism" and linked Tylenol with autism.
- An FDA press release stated that some studies have found an association between acetaminophen and autism but those studies have not established causation.
- On 2025-09-22, the U.S. Food and Drug Administration (FDA) said it would begin the process of updating the safety label for Tylenol and acetaminophen.
- At the 2025-09-22 White House press conference where President Trump linked acetaminophen to autism, the individuals reported as flanking him included Jay Bhattacharya, Marty Makary, Robert F. Kennedy Jr., and Mehmet Oz.
📰 Sources (2)
Trump says some medications will be sold at reduced "most-favored nation cost" in Pfizer deal
New information:
- President Trump said some medications will be sold at a 'most‑favored nation cost' under a deal with Pfizer.
- The president claimed some drug prices could fall by 50%–100%.